Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on TSX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on TSX
Today’s data is for companies listed on the TSX Venture Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| THCX | The Hydropothecary Corp | 2019 | 5.020000 | 7.7000 | CAD | 5 |
| XLY | Auxly Cannabis Group Inc | 2018 | 1.150000 | 3.0000 | CAD | 1 |
| KBLT | Cobalt 27 Capital Corp | 2018 | 9.750000 | 16.6286 | CAD | 7 |
| FIRE | The Supreme Cannabis Co Inc | 2019 | 1.660000 | 3.2000 | CAD | 4 |
| HIVE | HIVE Blockchain Technologies Ltd | 2019 | 0.980000 | 3.0750 | CAD | 2 |
| AM.H | HLS Therapeutics Inc | 2018 | 9.950000 | 14.5000 | CAD | 1 |
| HUT | Hut 8 Mining Corp | 2018 | 3.230000 | 7.8500 | CAD | 1 |
| BLN | Blackline Safety Corp | 2018 | 5.500000 | 7.6667 | CAD | 3 |
| PEA | Pieridae Energy Ltd | 2018 | 4.410000 | 8.5000 | CAD | 1 |
| LLG | Mason Graphite Inc | 2019 | 1.510000 | 3.3375 | CAD | 4 |
| FIL | Filo Mining Corp | 2018 | 2.220000 | 4.7000 | CAD | 3 |
| GENE | Invictus MD Strategies Corp | 2018 | 1.690000 | 3.3000 | CAD | 2 |
| NLC | Neo Lithium Corp | 2018 | 1.320000 | 2.8333 | CAD | 3 |
| RX | Biosyent Inc | 2018 | 9.800000 | 11.7500 | CAD | 2 |
| HVT | Harvest One Cannabis Inc | 2019 | 0.800000 | 2.2500 | CAD | 2 |
| MPH | Medicure Inc | 2018 | 7.550000 | 10.5000 | CAD | 2 |
| PRN | Profound Medical Corp | 2018 | 1.000000 | 3.0875 | CAD | 4 |
| BSR | Bluestone Resources Inc | 2018 | 1.400000 | 2.9000 | CAD | 3 |
| CKG | Chesapeake Gold Corp | 2018 | 2.220000 | 4.0000 | CAD | 1 |
| TLG | Troilus Gold Corp | 2018 | 1.400000 | 3.7500 | CAD | 5 |
| POE | Pan Orient Energy Corp | 2018 | 1.130000 | 3.2500 | CAD | 1 |
| CBX | Cortex Business Solutions Inc | 2019 | 4.050000 | 6.3667 | CAD | 3 |
| ACST | Acasti Pharma Inc | 2019 | 1.060000 | 4.0000 | CAD | 1 |
| KUU | KuuHubb Inc | 2019 | 0.530000 | 4.0000 | CAD | 2 |
| RP | RepliCel Life Sciences Inc | 2018 | 0.350000 | 2.1500 | CAD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
THCX:TSX Hydropothecary
http://www.thcx.com
Hydropothecary has 98 employees and is headquartered in Canada.
The Hydropothecary Corp is in the business of producing, marketing and selling of medical marijuana through its indirect wholly-owned subsidiary. The product lines include H2, Decarb, and Elixir No. 1.
FIRE:TSX The Supreme Cannabis
http://www.supreme.ca
The Supreme Cannabis has None employees and is headquartered in Canada.
The Supreme Cannabis Co Inc is engaged in production and sale of medical cannabis. The company is a cultivator and distributor of sun-grown cannabis through its wholly-owned subsidiary 7ACRES.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.